nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Cocaine—SCN10A—breast cancer	0.0025	0.134	CrCbGaD
Hyoscyamine—Granisetron—CYP1A1—breast cancer	0.00217	0.116	CrCbGaD
Hyoscyamine—Dolasetron—CYP2D6—breast cancer	0.00177	0.0947	CrCbGaD
Hyoscyamine—Cyclopentolate—BCHE—breast cancer	0.00171	0.0916	CrCbGaD
Hyoscyamine—Granisetron—CYP2D6—breast cancer	0.00162	0.0866	CrCbGaD
Hyoscyamine—Dolasetron—CYP3A4—breast cancer	0.00152	0.0812	CrCbGaD
Hyoscyamine—Granisetron—CYP3A4—breast cancer	0.00139	0.0743	CrCbGaD
Hyoscyamine—Methylphenidate—CYP2D6—breast cancer	0.00101	0.0544	CrCbGaD
Hyoscyamine—Dexmethylphenidate—CYP2D6—breast cancer	0.00101	0.0544	CrCbGaD
Hyoscyamine—Cocaine—CYP2D6—breast cancer	0.000769	0.0412	CrCbGaD
Hyoscyamine—Ipratropium bromide—CYP2D6—breast cancer	0.000703	0.0377	CrCbGaD
Hyoscyamine—Cocaine—CYP3A4—breast cancer	0.00066	0.0354	CrCbGaD
Hyoscyamine—Scopolamine—ABCB1—breast cancer	0.00065	0.0348	CrCbGaD
Hyoscyamine—Ipratropium bromide—CYP3A4—breast cancer	0.000603	0.0323	CrCbGaD
Hyoscyamine—Benzatropine—CYP2D6—breast cancer	0.000576	0.0309	CrCbGaD
Hyoscyamine—Dyspnoea—Paclitaxel—breast cancer	0.000269	0.000328	CcSEcCtD
Hyoscyamine—Headache—Thiotepa—breast cancer	0.000269	0.000327	CcSEcCtD
Hyoscyamine—Somnolence—Paclitaxel—breast cancer	0.000269	0.000327	CcSEcCtD
Hyoscyamine—Palpitations—Capecitabine—breast cancer	0.000269	0.000327	CcSEcCtD
Hyoscyamine—Chest pain—Docetaxel—breast cancer	0.000267	0.000326	CcSEcCtD
Hyoscyamine—Loss of consciousness—Capecitabine—breast cancer	0.000267	0.000325	CcSEcCtD
Hyoscyamine—Nausea—Vinorelbine—breast cancer	0.000267	0.000325	CcSEcCtD
Hyoscyamine—Dyspepsia—Paclitaxel—breast cancer	0.000266	0.000324	CcSEcCtD
Hyoscyamine—Asthenia—Mitoxantrone—breast cancer	0.000266	0.000324	CcSEcCtD
Hyoscyamine—Asthenia—Irinotecan—breast cancer	0.000266	0.000324	CcSEcCtD
Hyoscyamine—Conjunctivitis—Epirubicin—breast cancer	0.000263	0.000321	CcSEcCtD
Hyoscyamine—Dysuria—Doxorubicin—breast cancer	0.000263	0.00032	CcSEcCtD
Hyoscyamine—Hypersensitivity—Fluorouracil—breast cancer	0.000261	0.000319	CcSEcCtD
Hyoscyamine—Dry mouth—Docetaxel—breast cancer	0.000261	0.000318	CcSEcCtD
Hyoscyamine—Fatigue—Paclitaxel—breast cancer	0.000261	0.000317	CcSEcCtD
Hyoscyamine—Sweating—Epirubicin—breast cancer	0.00026	0.000316	CcSEcCtD
Hyoscyamine—Asthenia—Gemcitabine—breast cancer	0.000259	0.000315	CcSEcCtD
Hyoscyamine—Chest pain—Capecitabine—breast cancer	0.000259	0.000315	CcSEcCtD
Hyoscyamine—Pain—Paclitaxel—breast cancer	0.000258	0.000315	CcSEcCtD
Hyoscyamine—Constipation—Paclitaxel—breast cancer	0.000258	0.000315	CcSEcCtD
Hyoscyamine—Confusional state—Docetaxel—breast cancer	0.000258	0.000315	CcSEcCtD
Hyoscyamine—Anxiety—Capecitabine—breast cancer	0.000258	0.000314	CcSEcCtD
Hyoscyamine—Oedema—Docetaxel—breast cancer	0.000256	0.000312	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Docetaxel—breast cancer	0.000256	0.000312	CcSEcCtD
Hyoscyamine—Pruritus—Gemcitabine—breast cancer	0.000255	0.000311	CcSEcCtD
Hyoscyamine—Nausea—Thiotepa—breast cancer	0.000255	0.00031	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Doxorubicin—breast cancer	0.000254	0.000309	CcSEcCtD
Hyoscyamine—Diarrhoea—Irinotecan—breast cancer	0.000254	0.000309	CcSEcCtD
Hyoscyamine—Diarrhoea—Mitoxantrone—breast cancer	0.000254	0.000309	CcSEcCtD
Hyoscyamine—Dry mouth—Capecitabine—breast cancer	0.000253	0.000308	CcSEcCtD
Hyoscyamine—Shock—Docetaxel—breast cancer	0.000252	0.000307	CcSEcCtD
Hyoscyamine—Pruritus—Fluorouracil—breast cancer	0.000251	0.000306	CcSEcCtD
Hyoscyamine—Drowsiness—Doxorubicin—breast cancer	0.000251	0.000305	CcSEcCtD
Hyoscyamine—Confusional state—Capecitabine—breast cancer	0.00025	0.000305	CcSEcCtD
Hyoscyamine—Tachycardia—Docetaxel—breast cancer	0.00025	0.000305	CcSEcCtD
Hyoscyamine—Feeling abnormal—Paclitaxel—breast cancer	0.000249	0.000303	CcSEcCtD
Hyoscyamine—Oedema—Capecitabine—breast cancer	0.000248	0.000302	CcSEcCtD
Hyoscyamine—Bradycardia—Epirubicin—breast cancer	0.000248	0.000302	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Paclitaxel—breast cancer	0.000247	0.000301	CcSEcCtD
Hyoscyamine—Diarrhoea—Gemcitabine—breast cancer	0.000247	0.000301	CcSEcCtD
Hyoscyamine—Dizziness—Irinotecan—breast cancer	0.000245	0.000299	CcSEcCtD
Hyoscyamine—Shock—Capecitabine—breast cancer	0.000244	0.000297	CcSEcCtD
Hyoscyamine—Conjunctivitis—Doxorubicin—breast cancer	0.000244	0.000297	CcSEcCtD
Hyoscyamine—Diarrhoea—Fluorouracil—breast cancer	0.000243	0.000296	CcSEcCtD
Hyoscyamine—Tachycardia—Capecitabine—breast cancer	0.000242	0.000295	CcSEcCtD
Hyoscyamine—Sweating—Doxorubicin—breast cancer	0.00024	0.000293	CcSEcCtD
Hyoscyamine—Urticaria—Paclitaxel—breast cancer	0.00024	0.000292	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Capecitabine—breast cancer	0.00024	0.000292	CcSEcCtD
Hyoscyamine—Hypotension—Docetaxel—breast cancer	0.000239	0.000292	CcSEcCtD
Hyoscyamine—Abdominal pain—Paclitaxel—breast cancer	0.000239	0.000291	CcSEcCtD
Hyoscyamine—Body temperature increased—Paclitaxel—breast cancer	0.000239	0.000291	CcSEcCtD
Hyoscyamine—Vomiting—Mitoxantrone—breast cancer	0.000236	0.000287	CcSEcCtD
Hyoscyamine—Vomiting—Irinotecan—breast cancer	0.000236	0.000287	CcSEcCtD
Hyoscyamine—Dizziness—Fluorouracil—breast cancer	0.000235	0.000286	CcSEcCtD
Hyoscyamine—Rash—Irinotecan—breast cancer	0.000234	0.000285	CcSEcCtD
Hyoscyamine—Rash—Mitoxantrone—breast cancer	0.000234	0.000285	CcSEcCtD
Hyoscyamine—Dermatitis—Irinotecan—breast cancer	0.000233	0.000284	CcSEcCtD
Hyoscyamine—Dermatitis—Mitoxantrone—breast cancer	0.000233	0.000284	CcSEcCtD
Hyoscyamine—Headache—Irinotecan—breast cancer	0.000232	0.000283	CcSEcCtD
Hyoscyamine—Headache—Mitoxantrone—breast cancer	0.000232	0.000283	CcSEcCtD
Hyoscyamine—Hypotension—Capecitabine—breast cancer	0.000232	0.000282	CcSEcCtD
Hyoscyamine—Insomnia—Docetaxel—breast cancer	0.000232	0.000282	CcSEcCtD
Hyoscyamine—Vomiting—Gemcitabine—breast cancer	0.00023	0.00028	CcSEcCtD
Hyoscyamine—Bradycardia—Doxorubicin—breast cancer	0.000229	0.000279	CcSEcCtD
Hyoscyamine—Dyspnoea—Docetaxel—breast cancer	0.000228	0.000278	CcSEcCtD
Hyoscyamine—Somnolence—Docetaxel—breast cancer	0.000228	0.000277	CcSEcCtD
Hyoscyamine—Mental disorder—Methotrexate—breast cancer	0.000228	0.000277	CcSEcCtD
Hyoscyamine—Rash—Gemcitabine—breast cancer	0.000228	0.000277	CcSEcCtD
Hyoscyamine—Dermatitis—Gemcitabine—breast cancer	0.000227	0.000277	CcSEcCtD
Hyoscyamine—Erythema—Methotrexate—breast cancer	0.000226	0.000276	CcSEcCtD
Hyoscyamine—Headache—Gemcitabine—breast cancer	0.000226	0.000275	CcSEcCtD
Hyoscyamine—Flushing—Epirubicin—breast cancer	0.000226	0.000275	CcSEcCtD
Hyoscyamine—Vomiting—Fluorouracil—breast cancer	0.000226	0.000275	CcSEcCtD
Hyoscyamine—Dyspepsia—Docetaxel—breast cancer	0.000225	0.000275	CcSEcCtD
Hyoscyamine—Insomnia—Capecitabine—breast cancer	0.000224	0.000273	CcSEcCtD
Hyoscyamine—Rash—Fluorouracil—breast cancer	0.000224	0.000273	CcSEcCtD
Hyoscyamine—Dermatitis—Fluorouracil—breast cancer	0.000224	0.000272	CcSEcCtD
Hyoscyamine—Hypersensitivity—Paclitaxel—breast cancer	0.000223	0.000271	CcSEcCtD
Hyoscyamine—Headache—Fluorouracil—breast cancer	0.000222	0.000271	CcSEcCtD
Hyoscyamine—Dysgeusia—Methotrexate—breast cancer	0.000222	0.00027	CcSEcCtD
Hyoscyamine—Dyspnoea—Capecitabine—breast cancer	0.000221	0.000269	CcSEcCtD
Hyoscyamine—Fatigue—Docetaxel—breast cancer	0.000221	0.000269	CcSEcCtD
Hyoscyamine—Nausea—Mitoxantrone—breast cancer	0.00022	0.000268	CcSEcCtD
Hyoscyamine—Nausea—Irinotecan—breast cancer	0.00022	0.000268	CcSEcCtD
Hyoscyamine—Constipation—Docetaxel—breast cancer	0.000219	0.000267	CcSEcCtD
Hyoscyamine—Pain—Docetaxel—breast cancer	0.000219	0.000267	CcSEcCtD
Hyoscyamine—Dyspepsia—Capecitabine—breast cancer	0.000218	0.000266	CcSEcCtD
Hyoscyamine—Arrhythmia—Epirubicin—breast cancer	0.000217	0.000265	CcSEcCtD
Hyoscyamine—Asthenia—Paclitaxel—breast cancer	0.000217	0.000264	CcSEcCtD
Hyoscyamine—Nausea—Gemcitabine—breast cancer	0.000214	0.000261	CcSEcCtD
Hyoscyamine—Fatigue—Capecitabine—breast cancer	0.000214	0.00026	CcSEcCtD
Hyoscyamine—Pruritus—Paclitaxel—breast cancer	0.000214	0.00026	CcSEcCtD
Hyoscyamine—Vision blurred—Methotrexate—breast cancer	0.000213	0.00026	CcSEcCtD
Hyoscyamine—Mental disorder—Epirubicin—breast cancer	0.000213	0.00026	CcSEcCtD
Hyoscyamine—Pain—Capecitabine—breast cancer	0.000212	0.000258	CcSEcCtD
Hyoscyamine—Constipation—Capecitabine—breast cancer	0.000212	0.000258	CcSEcCtD
Hyoscyamine—Erythema—Epirubicin—breast cancer	0.000212	0.000258	CcSEcCtD
Hyoscyamine—Feeling abnormal—Docetaxel—breast cancer	0.000211	0.000257	CcSEcCtD
Hyoscyamine—Nausea—Fluorouracil—breast cancer	0.000211	0.000257	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Docetaxel—breast cancer	0.000209	0.000255	CcSEcCtD
Hyoscyamine—Flushing—Doxorubicin—breast cancer	0.000209	0.000254	CcSEcCtD
Hyoscyamine—Tension—Epirubicin—breast cancer	0.000208	0.000253	CcSEcCtD
Hyoscyamine—Dysgeusia—Epirubicin—breast cancer	0.000207	0.000253	CcSEcCtD
Hyoscyamine—Diarrhoea—Paclitaxel—breast cancer	0.000207	0.000252	CcSEcCtD
Hyoscyamine—Nervousness—Epirubicin—breast cancer	0.000206	0.00025	CcSEcCtD
Hyoscyamine—Feeling abnormal—Capecitabine—breast cancer	0.000204	0.000249	CcSEcCtD
Hyoscyamine—Vertigo—Methotrexate—breast cancer	0.000203	0.000248	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Capecitabine—breast cancer	0.000203	0.000247	CcSEcCtD
Hyoscyamine—Abdominal pain—Docetaxel—breast cancer	0.000202	0.000247	CcSEcCtD
Hyoscyamine—Body temperature increased—Docetaxel—breast cancer	0.000202	0.000247	CcSEcCtD
Hyoscyamine—Arrhythmia—Doxorubicin—breast cancer	0.000201	0.000245	CcSEcCtD
Hyoscyamine—Dizziness—Paclitaxel—breast cancer	0.0002	0.000243	CcSEcCtD
Hyoscyamine—Vision blurred—Epirubicin—breast cancer	0.0002	0.000243	CcSEcCtD
Hyoscyamine—Mental disorder—Doxorubicin—breast cancer	0.000197	0.00024	CcSEcCtD
Hyoscyamine—Urticaria—Capecitabine—breast cancer	0.000197	0.00024	CcSEcCtD
Hyoscyamine—Abdominal pain—Capecitabine—breast cancer	0.000196	0.000239	CcSEcCtD
Hyoscyamine—Body temperature increased—Capecitabine—breast cancer	0.000196	0.000239	CcSEcCtD
Hyoscyamine—Convulsion—Methotrexate—breast cancer	0.000196	0.000239	CcSEcCtD
Hyoscyamine—Erythema—Doxorubicin—breast cancer	0.000196	0.000239	CcSEcCtD
Hyoscyamine—Agitation—Epirubicin—breast cancer	0.000195	0.000237	CcSEcCtD
Hyoscyamine—Chest pain—Methotrexate—breast cancer	0.000193	0.000235	CcSEcCtD
Hyoscyamine—Tension—Doxorubicin—breast cancer	0.000192	0.000234	CcSEcCtD
Hyoscyamine—Vomiting—Paclitaxel—breast cancer	0.000192	0.000234	CcSEcCtD
Hyoscyamine—Dysgeusia—Doxorubicin—breast cancer	0.000192	0.000234	CcSEcCtD
Hyoscyamine—Rash—Paclitaxel—breast cancer	0.000191	0.000232	CcSEcCtD
Hyoscyamine—Dermatitis—Paclitaxel—breast cancer	0.00019	0.000232	CcSEcCtD
Hyoscyamine—Nervousness—Doxorubicin—breast cancer	0.00019	0.000232	CcSEcCtD
Hyoscyamine—Vertigo—Epirubicin—breast cancer	0.00019	0.000232	CcSEcCtD
Hyoscyamine—Syncope—Epirubicin—breast cancer	0.00019	0.000231	CcSEcCtD
Hyoscyamine—Headache—Paclitaxel—breast cancer	0.000189	0.000231	CcSEcCtD
Hyoscyamine—Hypersensitivity—Docetaxel—breast cancer	0.000189	0.00023	CcSEcCtD
Hyoscyamine—Palpitations—Epirubicin—breast cancer	0.000187	0.000228	CcSEcCtD
Hyoscyamine—Confusional state—Methotrexate—breast cancer	0.000186	0.000227	CcSEcCtD
Hyoscyamine—Loss of consciousness—Epirubicin—breast cancer	0.000186	0.000227	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Methotrexate—breast cancer	0.000185	0.000225	CcSEcCtD
Hyoscyamine—Vision blurred—Doxorubicin—breast cancer	0.000185	0.000225	CcSEcCtD
Hyoscyamine—Asthenia—Docetaxel—breast cancer	0.000184	0.000224	CcSEcCtD
Hyoscyamine—Convulsion—Epirubicin—breast cancer	0.000183	0.000223	CcSEcCtD
Hyoscyamine—Hypersensitivity—Capecitabine—breast cancer	0.000183	0.000223	CcSEcCtD
Hyoscyamine—Pruritus—Docetaxel—breast cancer	0.000181	0.000221	CcSEcCtD
Hyoscyamine—Chest pain—Epirubicin—breast cancer	0.00018	0.00022	CcSEcCtD
Hyoscyamine—Agitation—Doxorubicin—breast cancer	0.00018	0.000219	CcSEcCtD
Hyoscyamine—Anxiety—Epirubicin—breast cancer	0.00018	0.000219	CcSEcCtD
Hyoscyamine—Nausea—Paclitaxel—breast cancer	0.00018	0.000219	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Methotrexate—breast cancer	0.000178	0.000217	CcSEcCtD
Hyoscyamine—Asthenia—Capecitabine—breast cancer	0.000178	0.000217	CcSEcCtD
Hyoscyamine—Dry mouth—Epirubicin—breast cancer	0.000176	0.000215	CcSEcCtD
Hyoscyamine—Vertigo—Doxorubicin—breast cancer	0.000176	0.000214	CcSEcCtD
Hyoscyamine—Syncope—Doxorubicin—breast cancer	0.000176	0.000214	CcSEcCtD
Hyoscyamine—Pruritus—Capecitabine—breast cancer	0.000175	0.000214	CcSEcCtD
Hyoscyamine—Diarrhoea—Docetaxel—breast cancer	0.000175	0.000214	CcSEcCtD
Hyoscyamine—Confusional state—Epirubicin—breast cancer	0.000174	0.000212	CcSEcCtD
Hyoscyamine—Palpitations—Doxorubicin—breast cancer	0.000173	0.000211	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Epirubicin—breast cancer	0.000173	0.00021	CcSEcCtD
Hyoscyamine—Oedema—Epirubicin—breast cancer	0.000173	0.00021	CcSEcCtD
Hyoscyamine—Hypotension—Methotrexate—breast cancer	0.000173	0.00021	CcSEcCtD
Hyoscyamine—Loss of consciousness—Doxorubicin—breast cancer	0.000172	0.00021	CcSEcCtD
Hyoscyamine—Shock—Epirubicin—breast cancer	0.00017	0.000207	CcSEcCtD
Hyoscyamine—Convulsion—Doxorubicin—breast cancer	0.00017	0.000207	CcSEcCtD
Hyoscyamine—Diarrhoea—Capecitabine—breast cancer	0.00017	0.000207	CcSEcCtD
Hyoscyamine—Dizziness—Docetaxel—breast cancer	0.000169	0.000206	CcSEcCtD
Hyoscyamine—Tachycardia—Epirubicin—breast cancer	0.000169	0.000205	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Epirubicin—breast cancer	0.000167	0.000203	CcSEcCtD
Hyoscyamine—Insomnia—Methotrexate—breast cancer	0.000167	0.000203	CcSEcCtD
Hyoscyamine—Chest pain—Doxorubicin—breast cancer	0.000167	0.000203	CcSEcCtD
Hyoscyamine—Anxiety—Doxorubicin—breast cancer	0.000166	0.000202	CcSEcCtD
Hyoscyamine—Dyspnoea—Methotrexate—breast cancer	0.000165	0.000201	CcSEcCtD
Hyoscyamine—Somnolence—Methotrexate—breast cancer	0.000164	0.0002	CcSEcCtD
Hyoscyamine—Dizziness—Capecitabine—breast cancer	0.000164	0.0002	CcSEcCtD
Hyoscyamine—Dry mouth—Doxorubicin—breast cancer	0.000163	0.000199	CcSEcCtD
Hyoscyamine—Vomiting—Docetaxel—breast cancer	0.000163	0.000198	CcSEcCtD
Hyoscyamine—Dyspepsia—Methotrexate—breast cancer	0.000163	0.000198	CcSEcCtD
Hyoscyamine—Rash—Docetaxel—breast cancer	0.000162	0.000197	CcSEcCtD
Hyoscyamine—Hypotension—Epirubicin—breast cancer	0.000161	0.000197	CcSEcCtD
Hyoscyamine—Dermatitis—Docetaxel—breast cancer	0.000161	0.000197	CcSEcCtD
Hyoscyamine—Confusional state—Doxorubicin—breast cancer	0.000161	0.000196	CcSEcCtD
Hyoscyamine—Headache—Docetaxel—breast cancer	0.00016	0.000195	CcSEcCtD
Hyoscyamine—Oedema—Doxorubicin—breast cancer	0.00016	0.000195	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Doxorubicin—breast cancer	0.00016	0.000195	CcSEcCtD
Hyoscyamine—Fatigue—Methotrexate—breast cancer	0.000159	0.000194	CcSEcCtD
Hyoscyamine—Pain—Methotrexate—breast cancer	0.000158	0.000192	CcSEcCtD
Hyoscyamine—Vomiting—Capecitabine—breast cancer	0.000158	0.000192	CcSEcCtD
Hyoscyamine—Shock—Doxorubicin—breast cancer	0.000157	0.000192	CcSEcCtD
Hyoscyamine—Rash—Capecitabine—breast cancer	0.000156	0.00019	CcSEcCtD
Hyoscyamine—Insomnia—Epirubicin—breast cancer	0.000156	0.00019	CcSEcCtD
Hyoscyamine—Dermatitis—Capecitabine—breast cancer	0.000156	0.00019	CcSEcCtD
Hyoscyamine—Tachycardia—Doxorubicin—breast cancer	0.000156	0.00019	CcSEcCtD
Hyoscyamine—Headache—Capecitabine—breast cancer	0.000155	0.000189	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Doxorubicin—breast cancer	0.000155	0.000188	CcSEcCtD
Hyoscyamine—Dyspnoea—Epirubicin—breast cancer	0.000154	0.000188	CcSEcCtD
Hyoscyamine—Somnolence—Epirubicin—breast cancer	0.000154	0.000187	CcSEcCtD
Hyoscyamine—Nausea—Docetaxel—breast cancer	0.000152	0.000185	CcSEcCtD
Hyoscyamine—Feeling abnormal—Methotrexate—breast cancer	0.000152	0.000185	CcSEcCtD
Hyoscyamine—Dyspepsia—Epirubicin—breast cancer	0.000152	0.000185	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Methotrexate—breast cancer	0.000151	0.000184	CcSEcCtD
Hyoscyamine—Hypotension—Doxorubicin—breast cancer	0.000149	0.000182	CcSEcCtD
Hyoscyamine—Fatigue—Epirubicin—breast cancer	0.000149	0.000181	CcSEcCtD
Hyoscyamine—Constipation—Epirubicin—breast cancer	0.000148	0.00018	CcSEcCtD
Hyoscyamine—Pain—Epirubicin—breast cancer	0.000148	0.00018	CcSEcCtD
Hyoscyamine—Nausea—Capecitabine—breast cancer	0.000147	0.000179	CcSEcCtD
Hyoscyamine—Urticaria—Methotrexate—breast cancer	0.000147	0.000179	CcSEcCtD
Hyoscyamine—Abdominal pain—Methotrexate—breast cancer	0.000146	0.000178	CcSEcCtD
Hyoscyamine—Body temperature increased—Methotrexate—breast cancer	0.000146	0.000178	CcSEcCtD
Hyoscyamine—Insomnia—Doxorubicin—breast cancer	0.000145	0.000176	CcSEcCtD
Hyoscyamine—Dyspnoea—Doxorubicin—breast cancer	0.000143	0.000174	CcSEcCtD
Hyoscyamine—Feeling abnormal—Epirubicin—breast cancer	0.000142	0.000173	CcSEcCtD
Hyoscyamine—Somnolence—Doxorubicin—breast cancer	0.000142	0.000173	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Epirubicin—breast cancer	0.000141	0.000172	CcSEcCtD
Hyoscyamine—Dyspepsia—Doxorubicin—breast cancer	0.000141	0.000171	CcSEcCtD
Hyoscyamine—Fatigue—Doxorubicin—breast cancer	0.000138	0.000168	CcSEcCtD
Hyoscyamine—Urticaria—Epirubicin—breast cancer	0.000137	0.000167	CcSEcCtD
Hyoscyamine—Constipation—Doxorubicin—breast cancer	0.000137	0.000167	CcSEcCtD
Hyoscyamine—Pain—Doxorubicin—breast cancer	0.000137	0.000167	CcSEcCtD
Hyoscyamine—Abdominal pain—Epirubicin—breast cancer	0.000137	0.000166	CcSEcCtD
Hyoscyamine—Body temperature increased—Epirubicin—breast cancer	0.000137	0.000166	CcSEcCtD
Hyoscyamine—Hypersensitivity—Methotrexate—breast cancer	0.000136	0.000166	CcSEcCtD
Hyoscyamine—Asthenia—Methotrexate—breast cancer	0.000132	0.000161	CcSEcCtD
Hyoscyamine—Feeling abnormal—Doxorubicin—breast cancer	0.000132	0.00016	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Doxorubicin—breast cancer	0.000131	0.000159	CcSEcCtD
Hyoscyamine—Pruritus—Methotrexate—breast cancer	0.000131	0.000159	CcSEcCtD
Hyoscyamine—Hypersensitivity—Epirubicin—breast cancer	0.000127	0.000155	CcSEcCtD
Hyoscyamine—Urticaria—Doxorubicin—breast cancer	0.000127	0.000155	CcSEcCtD
Hyoscyamine—Body temperature increased—Doxorubicin—breast cancer	0.000126	0.000154	CcSEcCtD
Hyoscyamine—Abdominal pain—Doxorubicin—breast cancer	0.000126	0.000154	CcSEcCtD
Hyoscyamine—Diarrhoea—Methotrexate—breast cancer	0.000126	0.000154	CcSEcCtD
Hyoscyamine—Asthenia—Epirubicin—breast cancer	0.000124	0.000151	CcSEcCtD
Hyoscyamine—Pruritus—Epirubicin—breast cancer	0.000122	0.000149	CcSEcCtD
Hyoscyamine—Dizziness—Methotrexate—breast cancer	0.000122	0.000149	CcSEcCtD
Hyoscyamine—Diarrhoea—Epirubicin—breast cancer	0.000118	0.000144	CcSEcCtD
Hyoscyamine—Hypersensitivity—Doxorubicin—breast cancer	0.000118	0.000143	CcSEcCtD
Hyoscyamine—Vomiting—Methotrexate—breast cancer	0.000117	0.000143	CcSEcCtD
Hyoscyamine—Rash—Methotrexate—breast cancer	0.000116	0.000142	CcSEcCtD
Hyoscyamine—Dermatitis—Methotrexate—breast cancer	0.000116	0.000142	CcSEcCtD
Hyoscyamine—Headache—Methotrexate—breast cancer	0.000116	0.000141	CcSEcCtD
Hyoscyamine—Asthenia—Doxorubicin—breast cancer	0.000115	0.00014	CcSEcCtD
Hyoscyamine—Dizziness—Epirubicin—breast cancer	0.000114	0.000139	CcSEcCtD
Hyoscyamine—Pruritus—Doxorubicin—breast cancer	0.000113	0.000138	CcSEcCtD
Hyoscyamine—Vomiting—Epirubicin—breast cancer	0.00011	0.000134	CcSEcCtD
Hyoscyamine—Nausea—Methotrexate—breast cancer	0.00011	0.000134	CcSEcCtD
Hyoscyamine—Diarrhoea—Doxorubicin—breast cancer	0.000109	0.000133	CcSEcCtD
Hyoscyamine—Rash—Epirubicin—breast cancer	0.000109	0.000133	CcSEcCtD
Hyoscyamine—Dermatitis—Epirubicin—breast cancer	0.000109	0.000133	CcSEcCtD
Hyoscyamine—Headache—Epirubicin—breast cancer	0.000108	0.000132	CcSEcCtD
Hyoscyamine—Dizziness—Doxorubicin—breast cancer	0.000106	0.000129	CcSEcCtD
Hyoscyamine—Nausea—Epirubicin—breast cancer	0.000103	0.000125	CcSEcCtD
Hyoscyamine—Vomiting—Doxorubicin—breast cancer	0.000102	0.000124	CcSEcCtD
Hyoscyamine—Rash—Doxorubicin—breast cancer	0.000101	0.000123	CcSEcCtD
Hyoscyamine—Dermatitis—Doxorubicin—breast cancer	0.000101	0.000123	CcSEcCtD
Hyoscyamine—Headache—Doxorubicin—breast cancer	0.0001	0.000122	CcSEcCtD
Hyoscyamine—Nausea—Doxorubicin—breast cancer	9.5e-05	0.000116	CcSEcCtD
Hyoscyamine—CHRM2—Signaling Pathways—NRG1—breast cancer	2.68e-05	0.000167	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CD—breast cancer	2.68e-05	0.000167	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—E2F1—breast cancer	2.68e-05	0.000167	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—E2F1—breast cancer	2.67e-05	0.000166	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CB—breast cancer	2.66e-05	0.000166	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—H2AFX—breast cancer	2.66e-05	0.000166	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—IL2—breast cancer	2.66e-05	0.000166	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CB—breast cancer	2.65e-05	0.000165	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—PIK3CA—breast cancer	2.65e-05	0.000165	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SERPINE1—breast cancer	2.65e-05	0.000165	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—E2F1—breast cancer	2.64e-05	0.000165	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	2.63e-05	0.000164	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—KRAS—breast cancer	2.62e-05	0.000163	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SPP1—breast cancer	2.57e-05	0.00016	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SPP1—breast cancer	2.56e-05	0.00016	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CXCL8—breast cancer	2.56e-05	0.00016	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CXCL8—breast cancer	2.55e-05	0.000159	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ERBB3—breast cancer	2.54e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FGFR2—breast cancer	2.54e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SPP1—breast cancer	2.54e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ERBB3—breast cancer	2.53e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FGFR2—breast cancer	2.53e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NOS3—breast cancer	2.53e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CXCL8—breast cancer	2.53e-05	0.000157	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ERBB3—breast cancer	2.51e-05	0.000156	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FGFR2—breast cancer	2.51e-05	0.000156	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CG—breast cancer	2.45e-05	0.000153	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL2—breast cancer	2.45e-05	0.000152	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL2—breast cancer	2.44e-05	0.000152	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TERT—breast cancer	2.44e-05	0.000152	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TERT—breast cancer	2.43e-05	0.000151	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL2—breast cancer	2.41e-05	0.00015	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—PIK3CA—breast cancer	2.41e-05	0.00015	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TERT—breast cancer	2.41e-05	0.00015	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MDM2—breast cancer	2.4e-05	0.000149	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—RAF1—breast cancer	2.39e-05	0.000149	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—RELA—breast cancer	2.38e-05	0.000148	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FGFR1—breast cancer	2.37e-05	0.000147	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ERBB2—breast cancer	2.36e-05	0.000147	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FGFR1—breast cancer	2.36e-05	0.000147	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FGFR1—breast cancer	2.34e-05	0.000146	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MTOR—breast cancer	2.33e-05	0.000145	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CB—breast cancer	2.33e-05	0.000145	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HIF1A—breast cancer	2.33e-05	0.000145	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HIF1A—breast cancer	2.32e-05	0.000145	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HIF1A—breast cancer	2.3e-05	0.000143	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—LEP—breast cancer	2.28e-05	0.000142	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—LEP—breast cancer	2.27e-05	0.000141	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CAV1—breast cancer	2.25e-05	0.00014	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CAV1—breast cancer	2.25e-05	0.00014	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—LEP—breast cancer	2.25e-05	0.00014	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCL8—breast cancer	2.24e-05	0.00014	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KDR—breast cancer	2.23e-05	0.000139	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—HRAS—breast cancer	2.23e-05	0.000139	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CAV1—breast cancer	2.23e-05	0.000139	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KDR—breast cancer	2.22e-05	0.000138	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KDR—breast cancer	2.2e-05	0.000137	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CDKN1B—breast cancer	2.19e-05	0.000136	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ESR1—breast cancer	2.17e-05	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—AKT1—breast cancer	2.17e-05	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ESR1—breast cancer	2.17e-05	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CD—breast cancer	2.15e-05	0.000134	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CASP3—breast cancer	2.15e-05	0.000134	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FN1—breast cancer	2.15e-05	0.000134	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ESR1—breast cancer	2.14e-05	0.000134	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL2—breast cancer	2.14e-05	0.000134	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FN1—breast cancer	2.14e-05	0.000133	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—IL6—breast cancer	2.13e-05	0.000133	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ALB—breast cancer	2.12e-05	0.000132	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NFKBIA—breast cancer	2.12e-05	0.000132	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FN1—breast cancer	2.12e-05	0.000132	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NFKBIA—breast cancer	2.11e-05	0.000132	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NOTCH1—breast cancer	2.1e-05	0.000131	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NOTCH1—breast cancer	2.09e-05	0.00013	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NFKBIA—breast cancer	2.09e-05	0.00013	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCND1—breast cancer	2.09e-05	0.00013	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—JUN—breast cancer	2.08e-05	0.00013	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NOTCH1—breast cancer	2.07e-05	0.000129	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CTNNB1—breast cancer	2.07e-05	0.000129	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KIT—breast cancer	2.05e-05	0.000128	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APC—breast cancer	2.05e-05	0.000128	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CG—breast cancer	2.05e-05	0.000128	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KIT—breast cancer	2.05e-05	0.000128	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CG—breast cancer	2.05e-05	0.000128	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APC—breast cancer	2.05e-05	0.000128	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—NOS3—breast cancer	2.03e-05	0.000127	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EGF—breast cancer	2.03e-05	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MMP9—breast cancer	2.03e-05	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APC—breast cancer	2.03e-05	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CG—breast cancer	2.03e-05	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KIT—breast cancer	2.03e-05	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EGF—breast cancer	2.02e-05	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CDKN1A—breast cancer	2.02e-05	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PTEN—breast cancer	2.02e-05	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EGF—breast cancer	2e-05	0.000125	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MAPK8—breast cancer	1.97e-05	0.000123	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—AKT1—breast cancer	1.97e-05	0.000123	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—MAPK3—breast cancer	1.97e-05	0.000123	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—MAPK3—breast cancer	1.96e-05	0.000122	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—MAPK3—breast cancer	1.94e-05	0.000121	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—BRAF—breast cancer	1.93e-05	0.00012	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—BRAF—breast cancer	1.92e-05	0.00012	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—BRAF—breast cancer	1.91e-05	0.000119	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IGF1—breast cancer	1.88e-05	0.000117	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKT2—breast cancer	1.88e-05	0.000117	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CB—breast cancer	1.88e-05	0.000117	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IGF1—breast cancer	1.87e-05	0.000117	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKT2—breast cancer	1.87e-05	0.000117	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—EGFR—breast cancer	1.87e-05	0.000117	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SRC—breast cancer	1.87e-05	0.000117	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—EGFR—breast cancer	1.86e-05	0.000116	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PTGS2—breast cancer	1.86e-05	0.000116	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IGF1—breast cancer	1.86e-05	0.000116	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKT2—breast cancer	1.85e-05	0.000116	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—EGFR—breast cancer	1.85e-05	0.000115	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—VEGFA—breast cancer	1.82e-05	0.000114	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CD—breast cancer	1.81e-05	0.000112	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—STAT3—breast cancer	1.8e-05	0.000112	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CD—breast cancer	1.8e-05	0.000112	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	1.79e-05	0.000111	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SERPINE1—breast cancer	1.79e-05	0.000111	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3CA—breast cancer	1.78e-05	0.000111	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CD—breast cancer	1.78e-05	0.000111	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SERPINE1—breast cancer	1.78e-05	0.000111	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—KRAS—breast cancer	1.77e-05	0.00011	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	1.76e-05	0.00011	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SERPINE1—breast cancer	1.76e-05	0.00011	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—KRAS—breast cancer	1.76e-05	0.00011	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—KRAS—breast cancer	1.74e-05	0.000109	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MAPK3—breast cancer	1.72e-05	0.000107	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NOS3—breast cancer	1.7e-05	0.000106	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NOS3—breast cancer	1.7e-05	0.000106	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NOS3—breast cancer	1.68e-05	0.000105	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MYC—breast cancer	1.68e-05	0.000104	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TGFB1—breast cancer	1.67e-05	0.000104	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—EGFR—breast cancer	1.64e-05	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	1.62e-05	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PTEN—breast cancer	1.62e-05	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CA—breast cancer	1.62e-05	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MDM2—breast cancer	1.62e-05	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MDM2—breast cancer	1.61e-05	0.0001	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—RAF1—breast cancer	1.61e-05	0.0001	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RAF1—breast cancer	1.61e-05	0.0001	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—RELA—breast cancer	1.6e-05	0.0001	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	1.6e-05	9.99e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RELA—breast cancer	1.6e-05	9.97e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MDM2—breast cancer	1.6e-05	9.95e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ERBB2—breast cancer	1.59e-05	9.94e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—RAF1—breast cancer	1.59e-05	9.91e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ERBB2—breast cancer	1.59e-05	9.9e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—RELA—breast cancer	1.58e-05	9.87e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ERBB2—breast cancer	1.57e-05	9.81e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MTOR—breast cancer	1.57e-05	9.81e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CB—breast cancer	1.57e-05	9.81e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MTOR—breast cancer	1.57e-05	9.77e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CB—breast cancer	1.57e-05	9.77e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MTOR—breast cancer	1.55e-05	9.68e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CB—breast cancer	1.55e-05	9.68e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—KRAS—breast cancer	1.55e-05	9.65e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCL8—breast cancer	1.51e-05	9.42e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCL8—breast cancer	1.51e-05	9.39e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—HRAS—breast cancer	1.5e-05	9.36e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—HRAS—breast cancer	1.5e-05	9.33e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCL8—breast cancer	1.49e-05	9.3e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—HRAS—breast cancer	1.48e-05	9.24e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CDKN1B—breast cancer	1.48e-05	9.2e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CDKN1B—breast cancer	1.47e-05	9.17e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AKT1—breast cancer	1.46e-05	9.1e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CDKN1B—breast cancer	1.46e-05	9.08e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AKT1—breast cancer	1.46e-05	9.07e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CASP3—breast cancer	1.45e-05	9.02e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL2—breast cancer	1.44e-05	9.01e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CASP3—breast cancer	1.44e-05	8.99e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AKT1—breast cancer	1.44e-05	8.99e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL2—breast cancer	1.44e-05	8.98e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL6—breast cancer	1.44e-05	8.96e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL6—breast cancer	1.43e-05	8.93e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CASP3—breast cancer	1.43e-05	8.9e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL2—breast cancer	1.43e-05	8.89e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CA—breast cancer	1.42e-05	8.87e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL6—breast cancer	1.42e-05	8.85e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCND1—breast cancer	1.41e-05	8.78e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—JUN—breast cancer	1.41e-05	8.76e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCND1—breast cancer	1.4e-05	8.75e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—JUN—breast cancer	1.4e-05	8.73e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CTNNB1—breast cancer	1.39e-05	8.69e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCND1—breast cancer	1.39e-05	8.67e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CTNNB1—breast cancer	1.39e-05	8.67e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—JUN—breast cancer	1.39e-05	8.65e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CTNNB1—breast cancer	1.38e-05	8.58e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TP53—breast cancer	1.38e-05	8.58e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MMP9—breast cancer	1.37e-05	8.52e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MMP9—breast cancer	1.36e-05	8.5e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CDKN1A—breast cancer	1.36e-05	8.49e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PTEN—breast cancer	1.36e-05	8.47e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CDKN1A—breast cancer	1.36e-05	8.47e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PTEN—breast cancer	1.36e-05	8.45e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MMP9—breast cancer	1.35e-05	8.41e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CDKN1A—breast cancer	1.35e-05	8.38e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PTEN—breast cancer	1.34e-05	8.36e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MAPK8—breast cancer	1.33e-05	8.29e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AKT1—breast cancer	1.33e-05	8.27e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MAPK8—breast cancer	1.33e-05	8.26e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AKT1—breast cancer	1.32e-05	8.24e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—HRAS—breast cancer	1.32e-05	8.2e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MAPK8—breast cancer	1.31e-05	8.18e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AKT1—breast cancer	1.31e-05	8.16e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SRC—breast cancer	1.26e-05	7.86e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL6—breast cancer	1.26e-05	7.85e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SRC—breast cancer	1.26e-05	7.83e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SRC—breast cancer	1.24e-05	7.76e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—VEGFA—breast cancer	1.23e-05	7.65e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—VEGFA—breast cancer	1.22e-05	7.63e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—STAT3—breast cancer	1.22e-05	7.58e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—VEGFA—breast cancer	1.21e-05	7.55e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—STAT3—breast cancer	1.21e-05	7.55e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—STAT3—breast cancer	1.2e-05	7.48e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AKT1—breast cancer	1.16e-05	7.24e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MAPK3—breast cancer	1.16e-05	7.24e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MAPK3—breast cancer	1.16e-05	7.22e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MAPK3—breast cancer	1.15e-05	7.15e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CA—breast cancer	1.14e-05	7.13e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MYC—breast cancer	1.13e-05	7.04e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TGFB1—breast cancer	1.13e-05	7.02e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MYC—breast cancer	1.13e-05	7.02e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TGFB1—breast cancer	1.12e-05	7e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MYC—breast cancer	1.12e-05	6.95e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TGFB1—breast cancer	1.11e-05	6.93e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EGFR—breast cancer	1.11e-05	6.89e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EGFR—breast cancer	1.1e-05	6.87e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EGFR—breast cancer	1.09e-05	6.8e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KRAS—breast cancer	1.04e-05	6.51e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KRAS—breast cancer	1.04e-05	6.49e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KRAS—breast cancer	1.03e-05	6.42e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	9.59e-06	5.98e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CA—breast cancer	9.56e-06	5.96e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	9.47e-06	5.9e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AKT1—breast cancer	9.34e-06	5.82e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TP53—breast cancer	9.28e-06	5.78e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TP53—breast cancer	9.25e-06	5.76e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TP53—breast cancer	9.16e-06	5.71e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HRAS—breast cancer	8.87e-06	5.53e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HRAS—breast cancer	8.85e-06	5.51e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HRAS—breast cancer	8.76e-06	5.46e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL6—breast cancer	8.49e-06	5.29e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL6—breast cancer	8.47e-06	5.28e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL6—breast cancer	8.38e-06	5.23e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKT1—breast cancer	7.84e-06	4.88e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKT1—breast cancer	7.81e-06	4.87e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKT1—breast cancer	7.73e-06	4.82e-05	CbGpPWpGaD
